Making Ippondo a Subsidiary and Introducing the Welcia Model
First written in FY2019-Q1. 11 of 12 entries say "Advanced", first in FY2019-Q2. Latest entry: FY2022.
No other company in this theme has enough history to compare yet.
- FY2022AdvancedAnnual report
「During the current consolidated fiscal year, the group opened 144 stores, bringing the store count to 2,468 as of the end of the fiscal year.」
The foundation for deploying the Welcia model was expanded through 144 new store openings, the addition of regional drugstore companies to the group, and an increase in the store count to 2,468. - FY2022-Q3AdvancedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, the group opened 115 stores, bringing the store count to 2,312 as of the end of the third quarter.」
The foundation for deploying the Welcia model was expanded through the opening of 115 stores and an increase in the group store count to 2,312. - FY2022-Q2AdvancedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, the group opened 82 stores, bringing the store count to 2,287 as of the end of the second quarter.」
The foundation for deploying the Welcia model was expanded through the opening of 82 stores and an increase in the group store count to 2,287. - FY2022-Q1AdvancedAnnual report
「In March, ウエルシア薬局㈱, the company's consolidated subsidiary, as the surviving company, absorbed ㈱ネオファルマー and ㈱サミット, wholly owned subsidiaries of the company that operate dispensing pharmacy businesses mainly in Shikoku, centered on Ehime Prefecture, thereby improving business efficiency. The group had 2,258 stores at the end of the first quarter.」
The foundation for deploying the Welcia model was expanded through the absorption merger of ネオファルマー and サミット and the increase in the store count to 2,258. - FY2021-Q3AdvancedAnnual report
「Through active store openings and M&A, the group had 2,202 stores at the end of the third quarter. As a result of these initiatives, the company's consolidated results showed higher revenue and profit.」
The foundation for deploying the Welcia model was expanded through active store openings and M&A, bringing the store count to 2,202. - FY2021-Q2AdvancedAnnual report
「Through active M&A, the group added stores of ㈱よどや, ㈱クスリのマルエ, ㈱ネオファルマー, and ㈱サミット, which became subsidiaries during the cumulative second quarter of the current consolidated fiscal year, as well as newly opened stores. The group had 2,157 stores at the end of the second quarter.」
The foundation for deploying the Welcia model was expanded to 2,157 stores through the acquisition of several companies, including よどや, and new store openings. - FY2020-Q3AdvancedAnnual report
「In addition, to strengthen the business foundation in urban areas, the consolidated subsidiary ウエルシア薬局㈱ carried out organizational restructuring by merging with ㈱一本堂 in March and ㈱B.B.ON in September. For store expansion, the group focused on the Tohoku and Kinki regions and opened 105 stores. Including the 31 stores of 金光薬品㈱, which became a subsidiary in June, the group had 1,998 stores at the end of the third quarter.」
The merger of 一本堂 and B.B.ON, the addition of 31 金光薬品 stores, and the opening of 105 stores expanded the Welcia Group's store count to 1,998. - FY2020-Q2AdvancedAnnual report
「In addition, to strengthen the business foundation in urban areas, an organizational restructuring was carried out in March in which the consolidated subsidiary ウエルシア薬局㈱ was the surviving company in the merger and ㈱一本堂 was the absorbed company. Including the opening of 70 stores across the group, mainly in the Tohoku and Kinki regions, the store count was 1,976 at the end of the second quarter.」
Following the merger of 一本堂, 70 stores were opened, mainly in the Tohoku and Kinki regions, expanding the store count to 1,976. - FY2020-Q1AdvancedAnnual report
「In March, to strengthen the business foundation in urban areas, an organizational restructuring was carried out in which the consolidated subsidiary ウエルシア薬局㈱ was the surviving company in the merger and ㈱一本堂 was the absorbed company. The group opened 38 stores, mainly in the Tohoku and Kinki regions, among other initiatives, bringing the store count to 1,913 at the end of the fiscal year.」
The integration of 一本堂 following its acquisition as a subsidiary was completed through a merger in March. Together with the opening of 38 stores in priority regions, this increased the store count to 1,913. - FY2019AdvancedAnnual report
「For store expansion, we focused on the Tohoku and Kinki regions and opened 128 stores across the group. Including stores of the subsidiaries 一本堂 and ㈱ＭＡＳＡＹＡ, the group had 1,878 stores at the end of the current consolidated fiscal year.」
By making 一本堂 and MASAYA subsidiaries and opening 128 stores, the Welcia Group expanded its store count to 1,878. - FY2019-Q2AdvancedAnnual report
「For store expansion, we focused on the Tohoku and Kansai regions, opening 54 stores. Including the 41 stores of ㈱一本堂, which was made a subsidiary in March and operates primarily in Tokyo, the group had 1,773 stores at the end of the second quarter of the current consolidated fiscal year.」
Including 一本堂's 41 stores and the 54 new stores opened in Tohoku and Kansai, the Welcia Group expanded its store count to 1,773. - FY2019-Q1AchievedAnnual report
「We sought to expand our scale and pursue synergies by rapidly introducing the Welcia model at ㈱丸大サクラヰ薬局, which was made a subsidiary in September 2017 and is based in the Tohoku region, and at ㈱一本堂, which was made a subsidiary in March and operates primarily in Tokyo, among other initiatives.」
一本堂, which operates primarily in Tokyo, was made a subsidiary in March, and the introduction of the Welcia model and pursuit of group synergies began.